Table 1.
Characteristic | (as of March 15, 2020) | RT-PCR Results | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total | Positive | Negative | Difference* | (95% CI) | P value | |||||
(n) | (%) | (n) | (%) | (n) | (%) | |||||
758 | 100.00% | 59 | 7.78% | 699 | 92.22% | |||||
Age (years) | Minimum to maximum | 1–92 | / | 8–87 | / | 1–92 | / | −3.257 ± 2.279 | −7.731 to 1.217 | 0.1534 |
Median (interquartile) | 48 | (35–58) | 52 | (35–65) | 47 | (35–57) | ||||
Mean ± SD (95% CI) | 46.61 ± 16.82 | (45.41–47.81) | 49.61 ± 18.64 | (44.75–54.47) | 46.35 ± 16.65 | (45.12–47.59) | ||||
≥80 years | 13 | 1.72% | 3 | 5.09% | 10 | 1.43% | ||||
70–79 years | 50 | 6.60% | 4 | 6.78% | 46 | 6.58% | ||||
60–69 years | 120 | 15.83% | 13 | 22.03% | 107 | 15.31% | ||||
50–59 years | 158 | 20.84% | 13 | 22.03% | 145 | 20.73% | ||||
40–49 years | 153 | 20.18% | 5 | 8.47% | 148 | 21.17% | ||||
30–39 years | 148 | 19.53% | 10 | 16.95% | 138 | 19.75% | ||||
20–29 years | 76 | 10.02% | 9 | 15.25% | 67 | 9.59% | ||||
10–19 years | 19 | 2.51% | 1 | 1.70% | 18 | 2.58% | ||||
< 10 years | 21 | 2.77% | 1 | 1.70% | 20 | 2.86% | ||||
Sex | Male | 396 | 51.40% | 29 | 49.15% | 367 | 52.50% | −0.03351 ± 0.06780 | −0.1666 to 0.09958 | 0.62 |
Female | 362 | 48.60% | 30 | 50.85% | 332 | 47.50% | ||||
Severity of disease | Mild | 229 | 25.12% | 16 | 27.12% | 213 | 30.47% | 0.008608 ± 0.08114 | −0.1507 to 0.1679 | 0.92 |
Moderate | 465 | 67.63% | 40 | 67.80% | 425 | 60.80% | ||||
Severe | 60 | 6.67% | 3 | 5.08% | 57 | 8.16% | ||||
Critical | 4 | 0.58% | 0 | 0.00% | 4 | 0.57% |
*Difference between (Negative - Positive) ± SEM